Therapeutic targeting of tumor suppressor genes Journal Article


Authors: Morris, L. G. T.; Chan, T. A.
Article Title: Therapeutic targeting of tumor suppressor genes
Abstract: Carcinogenesis is a multistep process attributable to both gain-of-function mutations in oncogenes and loss-of-function mutations in tumor suppressor genes. Currently, most molecular targeted therapies are inhibitors of oncogenes, because inactivated tumor suppressor genes have proven harder to "drug." Nevertheless, in cancers, tumor suppressor genes undergo alteration more frequently than do oncogenes. In recent years, several promising strategies directed at tumor suppressor genes, or the pathways controlled by these genes, have emerged. Here, we describe advances in a number of different methodologies aimed at therapeutically targeting tumors driven by inactivated tumor suppressor genes. © 2014 American Cancer Society.
Keywords: oncogene; tumor suppressor gene; therapeutic targeting; cancer
Journal Title: Cancer
Volume: 121
Issue: 9
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2015-05-01
Start Page: 1357
End Page: 1368
Language: English
DOI: 10.1002/cncr.29140
PROVIDER: scopus
PUBMED: 25557041
PMCID: PMC4526158
DOI/URL:
Notes: Export Date: 4 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy Chan
    317 Chan
  2. Luc Morris
    278 Morris